# XORTX Therapeutics Inc.: Form 20-F for the period ended Dec 31, 2024

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 20-F
- Filed: 2025-05-12
- Accepted by EDGAR: May 9, 2025, 21:52 ET
- Period: 2024-12-31
- Accession: 0001410578-25-001183
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000141057825001183/tmb-20241231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000141057825001183/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000141057825001183/tmb-20241231x20f.htm

Filed May 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001410578-25-001183. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
